Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 5:26 PM
Ignite Modification Date: 2025-12-25 @ 3:00 PM
NCT ID: NCT00828568
Description: None
Frequency Threshold: 5
Time Frame: Assessed at 24 weeks
Study: NCT00828568
Study Brief: Bioequivalence Study of Two Imiquimod Cream 5%
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Imiquimod 5% Taro Imiquimod 5% manufactured by Taro applied for 16 weeks None None 4 183 22 183 View
Aldara - Imiquimod 5% Aldara, Imiquimod 5% applied for 16 weeks None None 6 179 22 179 View
Vehicle Patients receiving imiquimod Vehicle for 16 weeks None None 1 60 4 60 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
GASTROINTESTINAL HAEMORRHAGE None Gastrointestinal disorders MedDRA (11.1) View
HYPOTENSION None Vascular disorders MedDRA (11.1) View
NEPHROLITHIASIS None Renal and urinary disorders MedDRA (11.1) View
LOBAR PNEUMONIA None Infections and infestations MedDRA (11.1) View
TRANSIENT ISCHAEMIC ATTACK None Nervous system disorders MedDRA (11.1) View
CORONARY ARTERY OCCLUSION None Cardiac disorders MedDRA (11.1) View
ACUTE MYOCARDIAL INFARCTION None Cardiac disorders MedDRA (11.1) View
CEREBROVASCULAR ACCIDENT None Nervous system disorders MedDRA (11.1) View
DEHYDRATION None Metabolism and nutrition disorders MedDRA (11.1) View
SYNCOPE None Nervous system disorders MedDRA (11.1) View
NECK PAIN None Musculoskeletal and connective tissue disorders MedDRA (11.1) View
OSTEOARTHRITIS None Musculoskeletal and connective tissue disorders MedDRA (11.1) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
APPLICATION SITE PRURITUS None General disorders MedDRA (11.1) View
SQUAMOUS CELL CARCINOMA None Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA (11.1) View
APPLICATION SITE ERYTHEMA None General disorders MedDRA (11.1) View
APPLICATION SITE IRRITATION None General disorders MedDRA (11.1) View